SCHEMBL1935191

SCHEMBL1935191

N#C/C(=C\C=C\c1cccc(Cl)n1)C(=O)NCCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.59
MCL1 Q07820 1/20 0.52
LMNA P02545 4/20 0.48
GAA P10253 2/20 0.48
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 5/20 0.47
HPGD P15428 5/20 0.47
MEN1 O00255 4/20 0.47
MAPT P10636 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPK1 P28482 3/20 0.47
GMNN O75496 2/20 0.47
EGFR P00533 2/20 0.47
ERBB2 P04626 2/20 0.47
TP53 P04637 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47
ALOX15 P16050 2/20 0.47
ALOX12 P18054 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL841233 0.89 MCL1 (0.66) MAOBMCL1LMNAGAAALDH1A1
SCHEMBL841232 0.89 MCL1 (0.66) MAOBMCL1LMNAGAAALDH1A1
SCHEMBL1934858 0.88 MAOB (0.59) MAOBMCL1LMNAGAAALDH1A1
SCHEMBL873592 0.80 EGFR (0.59) LMNAGAAALDH1A1KDM4EHPGD
SCHEMBL841260 0.77 KMT2A (0.60) LMNAALDH1A1KDM4EHPGDMEN1
SCHEMBL1573453 0.77 KMT2A (0.60) LMNAALDH1A1KDM4EHPGDMEN1
SCHEMBL841259 0.77 KMT2A (0.60) LMNAALDH1A1KDM4EHPGDMEN1
SCHEMBL841782 0.77 KMT2A (0.60) LMNAALDH1A1KDM4EHPGDMEN1
SCHEMBL841781 0.77 KMT2A (0.60) LMNAALDH1A1KDM4EHPGDMEN1
SCHEMBL13678158 0.77 MAOB (0.78) MAOBMCL1LMNAGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2506852-A2 INTERFERON THERAPIES IN COMBINATION WITH BLOCKADE OF STAT3 ACTIVATION Board Of Regents, The University Of Texas System (US) 2012-10-10 EP disclosed
WO-2011069141-A2 INTERFERON THERAPIES IN COMBINATION WITH BLOCKADE OF STAT3 ACTIVATION BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2011-06-09 WO disclosed